nodes	percent_of_prediction	percent_of_DWPC	metapath
Buprenorphine—CYP2D6—Alzheimer's disease	0.2	1	CbGaD
Buprenorphine—CYP2A6—Memantine—Alzheimer's disease	0.125	0.283	CbGbCtD
Buprenorphine—CYP2D6—Rivastigmine—Alzheimer's disease	0.0567	0.129	CbGbCtD
Buprenorphine—CYP2C19—Memantine—Alzheimer's disease	0.0517	0.117	CbGbCtD
Buprenorphine—CYP2C9—Donepezil—Alzheimer's disease	0.0496	0.112	CbGbCtD
Buprenorphine—CYP2D6—Donepezil—Alzheimer's disease	0.0454	0.103	CbGbCtD
Buprenorphine—CYP3A4—Rivastigmine—Alzheimer's disease	0.0361	0.0818	CbGbCtD
Buprenorphine—CYP2D6—Galantamine—Alzheimer's disease	0.0292	0.0662	CbGbCtD
Buprenorphine—CYP3A4—Donepezil—Alzheimer's disease	0.0288	0.0654	CbGbCtD
Buprenorphine—CYP3A4—Galantamine—Alzheimer's disease	0.0186	0.0421	CbGbCtD
Buprenorphine—OPRM1—telencephalic ventricle—Alzheimer's disease	0.00384	0.118	CbGeAlD
Buprenorphine—OPRL1—forebrain—Alzheimer's disease	0.00286	0.0878	CbGeAlD
Buprenorphine—OPRL1—telencephalon—Alzheimer's disease	0.00263	0.0807	CbGeAlD
Buprenorphine—Naloxone—CREB1—Alzheimer's disease	0.00262	0.639	CrCbGaD
Buprenorphine—OPRL1—nervous system—Alzheimer's disease	0.00155	0.0477	CbGeAlD
Buprenorphine—OPRL1—central nervous system—Alzheimer's disease	0.00149	0.0459	CbGeAlD
Buprenorphine—OPRD1—forebrain—Alzheimer's disease	0.00147	0.0452	CbGeAlD
Buprenorphine—OPRK1—forebrain—Alzheimer's disease	0.00141	0.0434	CbGeAlD
Buprenorphine—OPRD1—telencephalon—Alzheimer's disease	0.00135	0.0416	CbGeAlD
Buprenorphine—OPRL1—brain—Alzheimer's disease	0.00119	0.0364	CbGeAlD
Buprenorphine—OPRM1—forebrain—Alzheimer's disease	0.001	0.0308	CbGeAlD
Buprenorphine—OPRM1—telencephalon—Alzheimer's disease	0.000923	0.0284	CbGeAlD
Buprenorphine—OPRD1—nervous system—Alzheimer's disease	0.000799	0.0246	CbGeAlD
Buprenorphine—OPRD1—central nervous system—Alzheimer's disease	0.000769	0.0236	CbGeAlD
Buprenorphine—OPRK1—nervous system—Alzheimer's disease	0.000766	0.0235	CbGeAlD
Buprenorphine—OPRK1—central nervous system—Alzheimer's disease	0.000738	0.0227	CbGeAlD
Buprenorphine—OPRK1—cerebellum—Alzheimer's disease	0.000721	0.0221	CbGeAlD
Buprenorphine—OPRD1—brain—Alzheimer's disease	0.000611	0.0188	CbGeAlD
Buprenorphine—OPRK1—brain—Alzheimer's disease	0.000586	0.018	CbGeAlD
Buprenorphine—Methylnaltrexone—CYP2D6—Alzheimer's disease	0.000557	0.136	CrCbGaD
Buprenorphine—CYP2A6—cerebellum—Alzheimer's disease	0.000549	0.0169	CbGeAlD
Buprenorphine—ABCB1—blood vessel—Alzheimer's disease	0.000549	0.0169	CbGeAlD
Buprenorphine—OPRM1—nervous system—Alzheimer's disease	0.000545	0.0167	CbGeAlD
Buprenorphine—ABCG2—telencephalon—Alzheimer's disease	0.00054	0.0166	CbGeAlD
Buprenorphine—OPRM1—central nervous system—Alzheimer's disease	0.000525	0.0161	CbGeAlD
Buprenorphine—Naloxone—ESR1—Alzheimer's disease	0.000509	0.124	CrCbGaD
Buprenorphine—CYP2A6—brain—Alzheimer's disease	0.000446	0.0137	CbGeAlD
Buprenorphine—OPRM1—brain—Alzheimer's disease	0.000417	0.0128	CbGeAlD
Buprenorphine—Oxymorphone—CYP2D6—Alzheimer's disease	0.000415	0.101	CrCbGaD
Buprenorphine—CYP2D6—forebrain—Alzheimer's disease	0.000402	0.0124	CbGeAlD
Buprenorphine—CYP2D6—telencephalon—Alzheimer's disease	0.00037	0.0114	CbGeAlD
Buprenorphine—ABCB1—embryo—Alzheimer's disease	0.000327	0.0101	CbGeAlD
Buprenorphine—Bradycardia—Memantine—Alzheimer's disease	0.000303	0.00129	CcSEcCtD
Buprenorphine—ABCG2—cerebellum—Alzheimer's disease	0.0003	0.00921	CbGeAlD
Buprenorphine—Rhinitis—Memantine—Alzheimer's disease	0.000299	0.00127	CcSEcCtD
Buprenorphine—Bradycardia—Rivastigmine—Alzheimer's disease	0.000297	0.00126	CcSEcCtD
Buprenorphine—Hallucination—Memantine—Alzheimer's disease	0.000296	0.00126	CcSEcCtD
Buprenorphine—Hypoaesthesia—Memantine—Alzheimer's disease	0.000296	0.00126	CcSEcCtD
Buprenorphine—Shock—Galantamine—Alzheimer's disease	0.000296	0.00126	CcSEcCtD
Buprenorphine—Pharyngitis—Memantine—Alzheimer's disease	0.000296	0.00125	CcSEcCtD
Buprenorphine—Nervous system disorder—Galantamine—Alzheimer's disease	0.000295	0.00125	CcSEcCtD
Buprenorphine—Chills—Donepezil—Alzheimer's disease	0.000294	0.00125	CcSEcCtD
Buprenorphine—Urinary tract disorder—Memantine—Alzheimer's disease	0.000294	0.00125	CcSEcCtD
Buprenorphine—Tachycardia—Galantamine—Alzheimer's disease	0.000294	0.00125	CcSEcCtD
Buprenorphine—Oedema peripheral—Memantine—Alzheimer's disease	0.000293	0.00124	CcSEcCtD
Buprenorphine—Connective tissue disorder—Memantine—Alzheimer's disease	0.000293	0.00124	CcSEcCtD
Buprenorphine—Rhinitis—Rivastigmine—Alzheimer's disease	0.000292	0.00124	CcSEcCtD
Buprenorphine—Skin disorder—Galantamine—Alzheimer's disease	0.000292	0.00124	CcSEcCtD
Buprenorphine—Urethral disorder—Memantine—Alzheimer's disease	0.000292	0.00124	CcSEcCtD
Buprenorphine—Hyperhidrosis—Galantamine—Alzheimer's disease	0.000291	0.00123	CcSEcCtD
Buprenorphine—Hypoaesthesia—Rivastigmine—Alzheimer's disease	0.00029	0.00123	CcSEcCtD
Buprenorphine—Hallucination—Rivastigmine—Alzheimer's disease	0.00029	0.00123	CcSEcCtD
Buprenorphine—ABCB1—forebrain—Alzheimer's disease	0.000289	0.00889	CbGeAlD
Buprenorphine—Pharyngitis—Rivastigmine—Alzheimer's disease	0.000289	0.00123	CcSEcCtD
Buprenorphine—Urinary tract disorder—Rivastigmine—Alzheimer's disease	0.000288	0.00122	CcSEcCtD
Buprenorphine—Mental disorder—Donepezil—Alzheimer's disease	0.000287	0.00122	CcSEcCtD
Buprenorphine—Oedema peripheral—Rivastigmine—Alzheimer's disease	0.000287	0.00122	CcSEcCtD
Buprenorphine—Visual impairment—Memantine—Alzheimer's disease	0.000287	0.00122	CcSEcCtD
Buprenorphine—Anorexia—Galantamine—Alzheimer's disease	0.000287	0.00122	CcSEcCtD
Buprenorphine—Connective tissue disorder—Rivastigmine—Alzheimer's disease	0.000286	0.00121	CcSEcCtD
Buprenorphine—Urethral disorder—Rivastigmine—Alzheimer's disease	0.000286	0.00121	CcSEcCtD
Buprenorphine—Erythema—Donepezil—Alzheimer's disease	0.000286	0.00121	CcSEcCtD
Buprenorphine—Malnutrition—Donepezil—Alzheimer's disease	0.000286	0.00121	CcSEcCtD
Buprenorphine—Flatulence—Donepezil—Alzheimer's disease	0.000281	0.00119	CcSEcCtD
Buprenorphine—Hypotension—Galantamine—Alzheimer's disease	0.000281	0.00119	CcSEcCtD
Buprenorphine—Visual impairment—Rivastigmine—Alzheimer's disease	0.000281	0.00119	CcSEcCtD
Buprenorphine—Tension—Donepezil—Alzheimer's disease	0.00028	0.00119	CcSEcCtD
Buprenorphine—Dysgeusia—Donepezil—Alzheimer's disease	0.00028	0.00119	CcSEcCtD
Buprenorphine—Eye disorder—Memantine—Alzheimer's disease	0.000278	0.00118	CcSEcCtD
Buprenorphine—Tinnitus—Memantine—Alzheimer's disease	0.000278	0.00118	CcSEcCtD
Buprenorphine—Nervousness—Donepezil—Alzheimer's disease	0.000277	0.00118	CcSEcCtD
Buprenorphine—Flushing—Memantine—Alzheimer's disease	0.000276	0.00117	CcSEcCtD
Buprenorphine—Cardiac disorder—Memantine—Alzheimer's disease	0.000276	0.00117	CcSEcCtD
Buprenorphine—Back pain—Donepezil—Alzheimer's disease	0.000276	0.00117	CcSEcCtD
Buprenorphine—Muscle spasms—Donepezil—Alzheimer's disease	0.000275	0.00116	CcSEcCtD
Buprenorphine—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.000274	0.00116	CcSEcCtD
Buprenorphine—Eye disorder—Rivastigmine—Alzheimer's disease	0.000272	0.00116	CcSEcCtD
Buprenorphine—Insomnia—Galantamine—Alzheimer's disease	0.000272	0.00115	CcSEcCtD
Buprenorphine—Tinnitus—Rivastigmine—Alzheimer's disease	0.000272	0.00115	CcSEcCtD
Buprenorphine—Cardiac disorder—Rivastigmine—Alzheimer's disease	0.00027	0.00115	CcSEcCtD
Buprenorphine—Flushing—Rivastigmine—Alzheimer's disease	0.00027	0.00115	CcSEcCtD
Buprenorphine—Angiopathy—Memantine—Alzheimer's disease	0.00027	0.00115	CcSEcCtD
Buprenorphine—Paraesthesia—Galantamine—Alzheimer's disease	0.00027	0.00115	CcSEcCtD
Buprenorphine—Vision blurred—Donepezil—Alzheimer's disease	0.000269	0.00114	CcSEcCtD
Buprenorphine—Immune system disorder—Memantine—Alzheimer's disease	0.000269	0.00114	CcSEcCtD
Buprenorphine—Mediastinal disorder—Memantine—Alzheimer's disease	0.000268	0.00114	CcSEcCtD
Buprenorphine—Tremor—Donepezil—Alzheimer's disease	0.000268	0.00114	CcSEcCtD
Buprenorphine—Somnolence—Galantamine—Alzheimer's disease	0.000267	0.00113	CcSEcCtD
Buprenorphine—Chills—Memantine—Alzheimer's disease	0.000267	0.00113	CcSEcCtD
Buprenorphine—ABCB1—telencephalon—Alzheimer's disease	0.000266	0.00818	CbGeAlD
Buprenorphine—Ill-defined disorder—Donepezil—Alzheimer's disease	0.000265	0.00112	CcSEcCtD
Buprenorphine—Dyspepsia—Galantamine—Alzheimer's disease	0.000265	0.00112	CcSEcCtD
Buprenorphine—Angiopathy—Rivastigmine—Alzheimer's disease	0.000264	0.00112	CcSEcCtD
Buprenorphine—Mediastinal disorder—Rivastigmine—Alzheimer's disease	0.000263	0.00111	CcSEcCtD
Buprenorphine—Agitation—Donepezil—Alzheimer's disease	0.000262	0.00111	CcSEcCtD
Buprenorphine—Chills—Rivastigmine—Alzheimer's disease	0.000262	0.00111	CcSEcCtD
Buprenorphine—Decreased appetite—Galantamine—Alzheimer's disease	0.000261	0.00111	CcSEcCtD
Buprenorphine—Mental disorder—Memantine—Alzheimer's disease	0.000261	0.00111	CcSEcCtD
Buprenorphine—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.00026	0.0011	CcSEcCtD
Buprenorphine—Malnutrition—Memantine—Alzheimer's disease	0.000259	0.0011	CcSEcCtD
Buprenorphine—Fatigue—Galantamine—Alzheimer's disease	0.000259	0.0011	CcSEcCtD
Buprenorphine—Malaise—Donepezil—Alzheimer's disease	0.000258	0.00109	CcSEcCtD
Buprenorphine—Constipation—Galantamine—Alzheimer's disease	0.000257	0.00109	CcSEcCtD
Buprenorphine—Vertigo—Donepezil—Alzheimer's disease	0.000257	0.00109	CcSEcCtD
Buprenorphine—Syncope—Donepezil—Alzheimer's disease	0.000256	0.00109	CcSEcCtD
Buprenorphine—Flatulence—Memantine—Alzheimer's disease	0.000256	0.00108	CcSEcCtD
Buprenorphine—Mental disorder—Rivastigmine—Alzheimer's disease	0.000255	0.00108	CcSEcCtD
Buprenorphine—Tension—Memantine—Alzheimer's disease	0.000254	0.00108	CcSEcCtD
Buprenorphine—Dysgeusia—Memantine—Alzheimer's disease	0.000254	0.00108	CcSEcCtD
Buprenorphine—Malnutrition—Rivastigmine—Alzheimer's disease	0.000254	0.00108	CcSEcCtD
Buprenorphine—Erythema—Rivastigmine—Alzheimer's disease	0.000254	0.00108	CcSEcCtD
Buprenorphine—Nervousness—Memantine—Alzheimer's disease	0.000252	0.00107	CcSEcCtD
Buprenorphine—Loss of consciousness—Donepezil—Alzheimer's disease	0.000251	0.00106	CcSEcCtD
Buprenorphine—Back pain—Memantine—Alzheimer's disease	0.000251	0.00106	CcSEcCtD
Buprenorphine—CYP2C8—brain—Alzheimer's disease	0.000251	0.0077	CbGeAlD
Buprenorphine—Flatulence—Rivastigmine—Alzheimer's disease	0.00025	0.00106	CcSEcCtD
Buprenorphine—Cough—Donepezil—Alzheimer's disease	0.000249	0.00106	CcSEcCtD
Buprenorphine—Tension—Rivastigmine—Alzheimer's disease	0.000249	0.00106	CcSEcCtD
Buprenorphine—Dysgeusia—Rivastigmine—Alzheimer's disease	0.000248	0.00105	CcSEcCtD
Buprenorphine—Feeling abnormal—Galantamine—Alzheimer's disease	0.000248	0.00105	CcSEcCtD
Buprenorphine—Convulsion—Donepezil—Alzheimer's disease	0.000247	0.00105	CcSEcCtD
Buprenorphine—Hypertension—Donepezil—Alzheimer's disease	0.000247	0.00105	CcSEcCtD
Buprenorphine—Nervousness—Rivastigmine—Alzheimer's disease	0.000246	0.00105	CcSEcCtD
Buprenorphine—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.000246	0.00104	CcSEcCtD
Buprenorphine—Back pain—Rivastigmine—Alzheimer's disease	0.000245	0.00104	CcSEcCtD
Buprenorphine—Vision blurred—Memantine—Alzheimer's disease	0.000244	0.00104	CcSEcCtD
Buprenorphine—Muscle spasms—Rivastigmine—Alzheimer's disease	0.000244	0.00103	CcSEcCtD
Buprenorphine—ABCG2—brain—Alzheimer's disease	0.000244	0.00748	CbGeAlD
Buprenorphine—Arthralgia—Donepezil—Alzheimer's disease	0.000243	0.00103	CcSEcCtD
Buprenorphine—Myalgia—Donepezil—Alzheimer's disease	0.000243	0.00103	CcSEcCtD
Buprenorphine—Chest pain—Donepezil—Alzheimer's disease	0.000243	0.00103	CcSEcCtD
Buprenorphine—Tremor—Memantine—Alzheimer's disease	0.000243	0.00103	CcSEcCtD
Buprenorphine—Anxiety—Donepezil—Alzheimer's disease	0.000242	0.00103	CcSEcCtD
Buprenorphine—Ill-defined disorder—Memantine—Alzheimer's disease	0.000241	0.00102	CcSEcCtD
Buprenorphine—Discomfort—Donepezil—Alzheimer's disease	0.00024	0.00102	CcSEcCtD
Buprenorphine—Vision blurred—Rivastigmine—Alzheimer's disease	0.000239	0.00101	CcSEcCtD
Buprenorphine—Agitation—Memantine—Alzheimer's disease	0.000238	0.00101	CcSEcCtD
Buprenorphine—Dry mouth—Donepezil—Alzheimer's disease	0.000238	0.00101	CcSEcCtD
Buprenorphine—Body temperature increased—Galantamine—Alzheimer's disease	0.000238	0.00101	CcSEcCtD
Buprenorphine—Abdominal pain—Galantamine—Alzheimer's disease	0.000238	0.00101	CcSEcCtD
Buprenorphine—Tremor—Rivastigmine—Alzheimer's disease	0.000238	0.00101	CcSEcCtD
Buprenorphine—Ill-defined disorder—Rivastigmine—Alzheimer's disease	0.000235	0.000999	CcSEcCtD
Buprenorphine—Confusional state—Donepezil—Alzheimer's disease	0.000235	0.000997	CcSEcCtD
Buprenorphine—Malaise—Memantine—Alzheimer's disease	0.000234	0.000992	CcSEcCtD
Buprenorphine—Agitation—Rivastigmine—Alzheimer's disease	0.000233	0.000989	CcSEcCtD
Buprenorphine—Oedema—Donepezil—Alzheimer's disease	0.000233	0.000989	CcSEcCtD
Buprenorphine—Vertigo—Memantine—Alzheimer's disease	0.000233	0.000988	CcSEcCtD
Buprenorphine—Syncope—Memantine—Alzheimer's disease	0.000233	0.000987	CcSEcCtD
Buprenorphine—Infection—Donepezil—Alzheimer's disease	0.000232	0.000982	CcSEcCtD
Buprenorphine—Shock—Donepezil—Alzheimer's disease	0.000229	0.000973	CcSEcCtD
Buprenorphine—Palpitations—Memantine—Alzheimer's disease	0.000229	0.000972	CcSEcCtD
Buprenorphine—Malaise—Rivastigmine—Alzheimer's disease	0.000229	0.00097	CcSEcCtD
Buprenorphine—Nervous system disorder—Donepezil—Alzheimer's disease	0.000229	0.00097	CcSEcCtD
Buprenorphine—Vertigo—Rivastigmine—Alzheimer's disease	0.000228	0.000967	CcSEcCtD
Buprenorphine—Loss of consciousness—Memantine—Alzheimer's disease	0.000228	0.000967	CcSEcCtD
Buprenorphine—Syncope—Rivastigmine—Alzheimer's disease	0.000228	0.000965	CcSEcCtD
Buprenorphine—Cough—Memantine—Alzheimer's disease	0.000226	0.00096	CcSEcCtD
Buprenorphine—Hyperhidrosis—Donepezil—Alzheimer's disease	0.000225	0.000956	CcSEcCtD
Buprenorphine—Convulsion—Memantine—Alzheimer's disease	0.000225	0.000953	CcSEcCtD
Buprenorphine—Palpitations—Rivastigmine—Alzheimer's disease	0.000224	0.000951	CcSEcCtD
Buprenorphine—Hypertension—Memantine—Alzheimer's disease	0.000224	0.00095	CcSEcCtD
Buprenorphine—Loss of consciousness—Rivastigmine—Alzheimer's disease	0.000223	0.000946	CcSEcCtD
Buprenorphine—Anorexia—Donepezil—Alzheimer's disease	0.000222	0.000943	CcSEcCtD
Buprenorphine—CYP3A4—nervous system—Alzheimer's disease	0.000222	0.00682	CbGeAlD
Buprenorphine—Hypersensitivity—Galantamine—Alzheimer's disease	0.000222	0.00094	CcSEcCtD
Buprenorphine—Cough—Rivastigmine—Alzheimer's disease	0.000221	0.000939	CcSEcCtD
Buprenorphine—Arthralgia—Memantine—Alzheimer's disease	0.000221	0.000937	CcSEcCtD
Buprenorphine—Chest pain—Memantine—Alzheimer's disease	0.000221	0.000937	CcSEcCtD
Buprenorphine—Myalgia—Memantine—Alzheimer's disease	0.000221	0.000937	CcSEcCtD
Buprenorphine—Anxiety—Memantine—Alzheimer's disease	0.00022	0.000933	CcSEcCtD
Buprenorphine—Convulsion—Rivastigmine—Alzheimer's disease	0.00022	0.000932	CcSEcCtD
Buprenorphine—Hypertension—Rivastigmine—Alzheimer's disease	0.000219	0.000929	CcSEcCtD
Buprenorphine—CYP2D6—nervous system—Alzheimer's disease	0.000218	0.00671	CbGeAlD
Buprenorphine—Discomfort—Memantine—Alzheimer's disease	0.000218	0.000925	CcSEcCtD
Buprenorphine—Hypotension—Donepezil—Alzheimer's disease	0.000218	0.000924	CcSEcCtD
Buprenorphine—Myalgia—Rivastigmine—Alzheimer's disease	0.000216	0.000916	CcSEcCtD
Buprenorphine—Arthralgia—Rivastigmine—Alzheimer's disease	0.000216	0.000916	CcSEcCtD
Buprenorphine—Chest pain—Rivastigmine—Alzheimer's disease	0.000216	0.000916	CcSEcCtD
Buprenorphine—Dry mouth—Memantine—Alzheimer's disease	0.000216	0.000916	CcSEcCtD
Buprenorphine—Asthenia—Galantamine—Alzheimer's disease	0.000216	0.000915	CcSEcCtD
Buprenorphine—Anxiety—Rivastigmine—Alzheimer's disease	0.000215	0.000913	CcSEcCtD
Buprenorphine—Unspecified disorder of skin and subcutaneous tissue—Rivastigmine—Alzheimer's disease	0.000215	0.00091	CcSEcCtD
Buprenorphine—CYP3A4—central nervous system—Alzheimer's disease	0.000214	0.00657	CbGeAlD
Buprenorphine—Confusional state—Memantine—Alzheimer's disease	0.000213	0.000905	CcSEcCtD
Buprenorphine—Discomfort—Rivastigmine—Alzheimer's disease	0.000213	0.000905	CcSEcCtD
Buprenorphine—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	0.000212	0.000901	CcSEcCtD
Buprenorphine—Oedema—Memantine—Alzheimer's disease	0.000212	0.000898	CcSEcCtD
Buprenorphine—Dry mouth—Rivastigmine—Alzheimer's disease	0.000211	0.000896	CcSEcCtD
Buprenorphine—Insomnia—Donepezil—Alzheimer's disease	0.000211	0.000894	CcSEcCtD
Buprenorphine—CYP2D6—central nervous system—Alzheimer's disease	0.00021	0.00646	CbGeAlD
Buprenorphine—Infection—Memantine—Alzheimer's disease	0.00021	0.000892	CcSEcCtD
Buprenorphine—Paraesthesia—Donepezil—Alzheimer's disease	0.000209	0.000888	CcSEcCtD
Buprenorphine—Confusional state—Rivastigmine—Alzheimer's disease	0.000209	0.000886	CcSEcCtD
Buprenorphine—Shock—Memantine—Alzheimer's disease	0.000208	0.000883	CcSEcCtD
Buprenorphine—Dyspnoea—Donepezil—Alzheimer's disease	0.000208	0.000882	CcSEcCtD
Buprenorphine—Nervous system disorder—Memantine—Alzheimer's disease	0.000208	0.00088	CcSEcCtD
Buprenorphine—Somnolence—Donepezil—Alzheimer's disease	0.000207	0.000879	CcSEcCtD
Buprenorphine—Oedema—Rivastigmine—Alzheimer's disease	0.000207	0.000878	CcSEcCtD
Buprenorphine—Tachycardia—Memantine—Alzheimer's disease	0.000207	0.000876	CcSEcCtD
Buprenorphine—Diarrhoea—Galantamine—Alzheimer's disease	0.000206	0.000873	CcSEcCtD
Buprenorphine—Infection—Rivastigmine—Alzheimer's disease	0.000206	0.000873	CcSEcCtD
Buprenorphine—CYP2D6—cerebellum—Alzheimer's disease	0.000206	0.00632	CbGeAlD
Buprenorphine—Skin disorder—Memantine—Alzheimer's disease	0.000206	0.000872	CcSEcCtD
Buprenorphine—Dyspepsia—Donepezil—Alzheimer's disease	0.000205	0.00087	CcSEcCtD
Buprenorphine—Hyperhidrosis—Memantine—Alzheimer's disease	0.000205	0.000868	CcSEcCtD
Buprenorphine—Shock—Rivastigmine—Alzheimer's disease	0.000204	0.000864	CcSEcCtD
Buprenorphine—Nervous system disorder—Rivastigmine—Alzheimer's disease	0.000203	0.000861	CcSEcCtD
Buprenorphine—Decreased appetite—Donepezil—Alzheimer's disease	0.000203	0.00086	CcSEcCtD
Buprenorphine—Tachycardia—Rivastigmine—Alzheimer's disease	0.000202	0.000857	CcSEcCtD
Buprenorphine—Anorexia—Memantine—Alzheimer's disease	0.000202	0.000856	CcSEcCtD
Buprenorphine—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.000201	0.000854	CcSEcCtD
Buprenorphine—Skin disorder—Rivastigmine—Alzheimer's disease	0.000201	0.000853	CcSEcCtD
Buprenorphine—Fatigue—Donepezil—Alzheimer's disease	0.000201	0.000853	CcSEcCtD
Buprenorphine—Hyperhidrosis—Rivastigmine—Alzheimer's disease	0.0002	0.000849	CcSEcCtD
Buprenorphine—Pain—Donepezil—Alzheimer's disease	0.000199	0.000846	CcSEcCtD
Buprenorphine—Constipation—Donepezil—Alzheimer's disease	0.000199	0.000846	CcSEcCtD
Buprenorphine—Dizziness—Galantamine—Alzheimer's disease	0.000199	0.000844	CcSEcCtD
Buprenorphine—Hypotension—Memantine—Alzheimer's disease	0.000198	0.000839	CcSEcCtD
Buprenorphine—Anorexia—Rivastigmine—Alzheimer's disease	0.000197	0.000837	CcSEcCtD
Buprenorphine—Hypotension—Rivastigmine—Alzheimer's disease	0.000193	0.000821	CcSEcCtD
Buprenorphine—Musculoskeletal discomfort—Memantine—Alzheimer's disease	0.000193	0.000818	CcSEcCtD
Buprenorphine—Feeling abnormal—Donepezil—Alzheimer's disease	0.000192	0.000815	CcSEcCtD
Buprenorphine—Insomnia—Memantine—Alzheimer's disease	0.000191	0.000812	CcSEcCtD
Buprenorphine—Vomiting—Galantamine—Alzheimer's disease	0.000191	0.000811	CcSEcCtD
Buprenorphine—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.000191	0.000809	CcSEcCtD
Buprenorphine—Paraesthesia—Memantine—Alzheimer's disease	0.00019	0.000806	CcSEcCtD
Buprenorphine—Rash—Galantamine—Alzheimer's disease	0.00019	0.000804	CcSEcCtD
Buprenorphine—Dermatitis—Galantamine—Alzheimer's disease	0.000189	0.000804	CcSEcCtD
Buprenorphine—Dyspnoea—Memantine—Alzheimer's disease	0.000189	0.0008	CcSEcCtD
Buprenorphine—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	0.000189	0.0008	CcSEcCtD
Buprenorphine—Headache—Galantamine—Alzheimer's disease	0.000188	0.000799	CcSEcCtD
Buprenorphine—Somnolence—Memantine—Alzheimer's disease	0.000188	0.000798	CcSEcCtD
Buprenorphine—Insomnia—Rivastigmine—Alzheimer's disease	0.000187	0.000794	CcSEcCtD
Buprenorphine—Dyspepsia—Memantine—Alzheimer's disease	0.000186	0.00079	CcSEcCtD
Buprenorphine—Paraesthesia—Rivastigmine—Alzheimer's disease	0.000186	0.000789	CcSEcCtD
Buprenorphine—Urticaria—Donepezil—Alzheimer's disease	0.000185	0.000786	CcSEcCtD
Buprenorphine—Dyspnoea—Rivastigmine—Alzheimer's disease	0.000185	0.000783	CcSEcCtD
Buprenorphine—Body temperature increased—Donepezil—Alzheimer's disease	0.000184	0.000782	CcSEcCtD
Buprenorphine—Abdominal pain—Donepezil—Alzheimer's disease	0.000184	0.000782	CcSEcCtD
Buprenorphine—Somnolence—Rivastigmine—Alzheimer's disease	0.000184	0.000781	CcSEcCtD
Buprenorphine—Decreased appetite—Memantine—Alzheimer's disease	0.000184	0.00078	CcSEcCtD
Buprenorphine—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.000183	0.000775	CcSEcCtD
Buprenorphine—Fatigue—Memantine—Alzheimer's disease	0.000182	0.000774	CcSEcCtD
Buprenorphine—Dyspepsia—Rivastigmine—Alzheimer's disease	0.000182	0.000773	CcSEcCtD
Buprenorphine—Pain—Memantine—Alzheimer's disease	0.000181	0.000768	CcSEcCtD
Buprenorphine—Constipation—Memantine—Alzheimer's disease	0.000181	0.000768	CcSEcCtD
Buprenorphine—Decreased appetite—Rivastigmine—Alzheimer's disease	0.00018	0.000764	CcSEcCtD
Buprenorphine—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.000179	0.000758	CcSEcCtD
Buprenorphine—Nausea—Galantamine—Alzheimer's disease	0.000179	0.000758	CcSEcCtD
Buprenorphine—Fatigue—Rivastigmine—Alzheimer's disease	0.000179	0.000757	CcSEcCtD
Buprenorphine—Pain—Rivastigmine—Alzheimer's disease	0.000177	0.000751	CcSEcCtD
Buprenorphine—Constipation—Rivastigmine—Alzheimer's disease	0.000177	0.000751	CcSEcCtD
Buprenorphine—Feeling abnormal—Memantine—Alzheimer's disease	0.000174	0.00074	CcSEcCtD
Buprenorphine—Gastrointestinal pain—Memantine—Alzheimer's disease	0.000173	0.000734	CcSEcCtD
Buprenorphine—Hypersensitivity—Donepezil—Alzheimer's disease	0.000172	0.000729	CcSEcCtD
Buprenorphine—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.000171	0.000724	CcSEcCtD
Buprenorphine—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.000169	0.000718	CcSEcCtD
Buprenorphine—Urticaria—Memantine—Alzheimer's disease	0.000168	0.000713	CcSEcCtD
Buprenorphine—Abdominal pain—Memantine—Alzheimer's disease	0.000167	0.00071	CcSEcCtD
Buprenorphine—Body temperature increased—Memantine—Alzheimer's disease	0.000167	0.00071	CcSEcCtD
Buprenorphine—Asthenia—Donepezil—Alzheimer's disease	0.000167	0.000709	CcSEcCtD
Buprenorphine—CYP2D6—brain—Alzheimer's disease	0.000167	0.00513	CbGeAlD
Buprenorphine—Pruritus—Donepezil—Alzheimer's disease	0.000165	0.0007	CcSEcCtD
Buprenorphine—Urticaria—Rivastigmine—Alzheimer's disease	0.000164	0.000698	CcSEcCtD
Buprenorphine—Abdominal pain—Rivastigmine—Alzheimer's disease	0.000164	0.000694	CcSEcCtD
Buprenorphine—Body temperature increased—Rivastigmine—Alzheimer's disease	0.000164	0.000694	CcSEcCtD
Buprenorphine—Diarrhoea—Donepezil—Alzheimer's disease	0.000159	0.000677	CcSEcCtD
Buprenorphine—ABCB1—nervous system—Alzheimer's disease	0.000157	0.00483	CbGeAlD
Buprenorphine—Hypersensitivity—Memantine—Alzheimer's disease	0.000156	0.000661	CcSEcCtD
Buprenorphine—Dizziness—Donepezil—Alzheimer's disease	0.000154	0.000654	CcSEcCtD
Buprenorphine—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.000153	0.000647	CcSEcCtD
Buprenorphine—Asthenia—Memantine—Alzheimer's disease	0.000152	0.000644	CcSEcCtD
Buprenorphine—ABCB1—central nervous system—Alzheimer's disease	0.000151	0.00465	CbGeAlD
Buprenorphine—Pruritus—Memantine—Alzheimer's disease	0.00015	0.000635	CcSEcCtD
Buprenorphine—Asthenia—Rivastigmine—Alzheimer's disease	0.000149	0.00063	CcSEcCtD
Buprenorphine—Vomiting—Donepezil—Alzheimer's disease	0.000148	0.000629	CcSEcCtD
Buprenorphine—ABCB1—cerebellum—Alzheimer's disease	0.000148	0.00454	CbGeAlD
Buprenorphine—Rash—Donepezil—Alzheimer's disease	0.000147	0.000623	CcSEcCtD
Buprenorphine—Dermatitis—Donepezil—Alzheimer's disease	0.000147	0.000623	CcSEcCtD
Buprenorphine—Pruritus—Rivastigmine—Alzheimer's disease	0.000146	0.000621	CcSEcCtD
Buprenorphine—Headache—Donepezil—Alzheimer's disease	0.000146	0.000619	CcSEcCtD
Buprenorphine—Diarrhoea—Memantine—Alzheimer's disease	0.000145	0.000614	CcSEcCtD
Buprenorphine—Diarrhoea—Rivastigmine—Alzheimer's disease	0.000142	0.000601	CcSEcCtD
Buprenorphine—Dizziness—Memantine—Alzheimer's disease	0.00014	0.000594	CcSEcCtD
Buprenorphine—Nausea—Donepezil—Alzheimer's disease	0.000138	0.000587	CcSEcCtD
Buprenorphine—Dizziness—Rivastigmine—Alzheimer's disease	0.000137	0.000581	CcSEcCtD
Buprenorphine—Vomiting—Memantine—Alzheimer's disease	0.000135	0.000571	CcSEcCtD
Buprenorphine—Rash—Memantine—Alzheimer's disease	0.000133	0.000566	CcSEcCtD
Buprenorphine—Dermatitis—Memantine—Alzheimer's disease	0.000133	0.000566	CcSEcCtD
Buprenorphine—Headache—Memantine—Alzheimer's disease	0.000133	0.000562	CcSEcCtD
Buprenorphine—Vomiting—Rivastigmine—Alzheimer's disease	0.000132	0.000558	CcSEcCtD
Buprenorphine—Rash—Rivastigmine—Alzheimer's disease	0.000131	0.000554	CcSEcCtD
Buprenorphine—Dermatitis—Rivastigmine—Alzheimer's disease	0.00013	0.000553	CcSEcCtD
Buprenorphine—Headache—Rivastigmine—Alzheimer's disease	0.00013	0.00055	CcSEcCtD
Buprenorphine—Nausea—Memantine—Alzheimer's disease	0.000126	0.000533	CcSEcCtD
Buprenorphine—Nausea—Rivastigmine—Alzheimer's disease	0.000123	0.000522	CcSEcCtD
Buprenorphine—ABCB1—brain—Alzheimer's disease	0.00012	0.00369	CbGeAlD
Buprenorphine—CYP1A2—Metabolism—CHAT—Alzheimer's disease	7.63e-06	8.86e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—CCR5—Alzheimer's disease	7.61e-06	8.84e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—ACHE—Alzheimer's disease	7.59e-06	8.82e-05	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—NOTCH1—Alzheimer's disease	7.56e-06	8.78e-05	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—AKT1—Alzheimer's disease	7.53e-06	8.75e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—INPP5D—Alzheimer's disease	7.5e-06	8.72e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—HTR2A—Alzheimer's disease	7.45e-06	8.65e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—ACHE—Alzheimer's disease	7.41e-06	8.61e-05	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—BCHE—Alzheimer's disease	7.41e-06	8.61e-05	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—PPARG—Alzheimer's disease	7.37e-06	8.57e-05	CbGpPWpGaD
Buprenorphine—CYP2C18—Metabolism—PTGS2—Alzheimer's disease	7.34e-06	8.53e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—INPP5D—Alzheimer's disease	7.32e-06	8.51e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—MAOB—Alzheimer's disease	7.31e-06	8.5e-05	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—INS—Alzheimer's disease	7.23e-06	8.4e-05	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—CALM1—Alzheimer's disease	7.21e-06	8.37e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—Alzheimer's disease	7.19e-06	8.36e-05	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—APOE—Alzheimer's disease	7.18e-06	8.35e-05	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—CALM1—Alzheimer's disease	7.14e-06	8.3e-05	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—APOE—Alzheimer's disease	7.12e-06	8.27e-05	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—CAV1—Alzheimer's disease	7.12e-06	8.27e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—PTGS1—Alzheimer's disease	7.11e-06	8.27e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—ENO1—Alzheimer's disease	7.11e-06	8.27e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	7.09e-06	8.24e-05	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—GSK3B—Alzheimer's disease	7.09e-06	8.24e-05	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—CAV1—Alzheimer's disease	7.05e-06	8.2e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—GAPDH—Alzheimer's disease	7.04e-06	8.18e-05	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—CREB1—Alzheimer's disease	7.04e-06	8.17e-05	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—MTHFR—Alzheimer's disease	7.01e-06	8.14e-05	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—NOS3—Alzheimer's disease	7e-06	8.13e-05	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—INS—Alzheimer's disease	7e-06	8.13e-05	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—PLCB1—Alzheimer's disease	6.99e-06	8.12e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—ACHE—Alzheimer's disease	6.98e-06	8.11e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—CYP2D6—Alzheimer's disease	6.98e-06	8.11e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	6.96e-06	8.09e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—CALM1—Alzheimer's disease	6.95e-06	8.07e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—ENO1—Alzheimer's disease	6.94e-06	8.07e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—PTGS1—Alzheimer's disease	6.94e-06	8.07e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—ACHE—Alzheimer's disease	6.92e-06	8.04e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—APOE—Alzheimer's disease	6.92e-06	8.04e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—LEP—Alzheimer's disease	6.92e-06	8.04e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—INPP5D—Alzheimer's disease	6.9e-06	8.02e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	6.9e-06	8.01e-05	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—CCL2—Alzheimer's disease	6.88e-06	8e-05	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	6.86e-06	7.97e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—CAV1—Alzheimer's disease	6.86e-06	7.97e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—INPP5D—Alzheimer's disease	6.84e-06	7.95e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—CYP2D6—Alzheimer's disease	6.81e-06	7.91e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—A2M—Alzheimer's disease	6.8e-06	7.9e-05	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—ABCA1—Alzheimer's disease	6.78e-06	7.87e-05	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—IGF1—Alzheimer's disease	6.77e-06	7.86e-05	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—PPARGC1A—Alzheimer's disease	6.74e-06	7.84e-05	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—HMOX1—Alzheimer's disease	6.71e-06	7.8e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—BCHE—Alzheimer's disease	6.61e-06	7.68e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—ESR1—Alzheimer's disease	6.61e-06	7.68e-05	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—CALM1—Alzheimer's disease	6.55e-06	7.61e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—PTGS1—Alzheimer's disease	6.54e-06	7.6e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—ENO1—Alzheimer's disease	6.54e-06	7.6e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—F2—Alzheimer's disease	6.53e-06	7.58e-05	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—APOE—Alzheimer's disease	6.53e-06	7.58e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—ENO1—Alzheimer's disease	6.49e-06	7.54e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—PTGS1—Alzheimer's disease	6.49e-06	7.54e-05	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—CAV1—Alzheimer's disease	6.47e-06	7.51e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—BCHE—Alzheimer's disease	6.45e-06	7.5e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—NOTCH1—Alzheimer's disease	6.39e-06	7.42e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—CYP2D6—Alzheimer's disease	6.36e-06	7.39e-05	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—NOS3—Alzheimer's disease	6.34e-06	7.37e-05	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—PPARG—Alzheimer's disease	6.26e-06	7.27e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—PLCB1—Alzheimer's disease	6.24e-06	7.25e-05	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—PPARG—Alzheimer's disease	6.2e-06	7.2e-05	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—LPL—Alzheimer's disease	6.14e-06	7.13e-05	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—INS—Alzheimer's disease	6.14e-06	7.13e-05	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—NOS3—Alzheimer's disease	6.14e-06	7.13e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	6.12e-06	7.11e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—PLCB1—Alzheimer's disease	6.09e-06	7.08e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—BCHE—Alzheimer's disease	6.08e-06	7.07e-05	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—INS—Alzheimer's disease	6.08e-06	7.07e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	6.06e-06	7.04e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—ABCA1—Alzheimer's disease	6.05e-06	7.03e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—BCHE—Alzheimer's disease	6.03e-06	7.01e-05	CbGpPWpGaD
Buprenorphine—OPRD1—GPCR downstream signaling—AKT1—Alzheimer's disease	6e-06	6.97e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—GSK3B—Alzheimer's disease	5.99e-06	6.96e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—CREB1—Alzheimer's disease	5.95e-06	6.91e-05	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—CASP3—Alzheimer's disease	5.94e-06	6.9e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—ACHE—Alzheimer's disease	5.92e-06	6.87e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—INS—Alzheimer's disease	5.91e-06	6.87e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—ABCA1—Alzheimer's disease	5.9e-06	6.86e-05	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling by GPCR—IL6—Alzheimer's disease	5.9e-06	6.86e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—CHAT—Alzheimer's disease	5.89e-06	6.84e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—TPI1—Alzheimer's disease	5.89e-06	6.84e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—INPP5D—Alzheimer's disease	5.85e-06	6.79e-05	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—PPARGC1A—Alzheimer's disease	5.84e-06	6.79e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—CCL2—Alzheimer's disease	5.82e-06	6.76e-05	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—HMOX1—Alzheimer's disease	5.81e-06	6.76e-05	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—PTGS2—Alzheimer's disease	5.8e-06	6.74e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—PLCB1—Alzheimer's disease	5.74e-06	6.67e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—IGF1—Alzheimer's disease	5.72e-06	6.65e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—PLCB1—Alzheimer's disease	5.69e-06	6.61e-05	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—PPARG—Alzheimer's disease	5.68e-06	6.6e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—MAOB—Alzheimer's disease	5.64e-06	6.56e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	5.58e-06	6.49e-05	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—INS—Alzheimer's disease	5.57e-06	6.48e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—ABCA1—Alzheimer's disease	5.56e-06	6.46e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—PTGS1—Alzheimer's disease	5.54e-06	6.44e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—ENO1—Alzheimer's disease	5.54e-06	6.44e-05	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—MTHFR—Alzheimer's disease	5.53e-06	6.42e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—ABCA1—Alzheimer's disease	5.52e-06	6.41e-05	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—MAPK8—Alzheimer's disease	5.46e-06	6.34e-05	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling by GPCR—AKT1—Alzheimer's disease	5.44e-06	6.33e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—CYP2D6—Alzheimer's disease	5.44e-06	6.32e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—GAPDH—Alzheimer's disease	5.43e-06	6.31e-05	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—NOS3—Alzheimer's disease	5.38e-06	6.25e-05	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—NOS3—Alzheimer's disease	5.33e-06	6.2e-05	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—LPL—Alzheimer's disease	5.32e-06	6.18e-05	CbGpPWpGaD
Buprenorphine—OPRK1—GPCR downstream signaling—AKT1—Alzheimer's disease	5.26e-06	6.11e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—A2M—Alzheimer's disease	5.25e-06	6.1e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—PPARGC1A—Alzheimer's disease	5.21e-06	6.06e-05	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—CASP3—Alzheimer's disease	5.21e-06	6.05e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—HMOX1—Alzheimer's disease	5.19e-06	6.03e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—NOS3—Alzheimer's disease	5.19e-06	6.02e-05	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling by GPCR—IL6—Alzheimer's disease	5.18e-06	6.01e-05	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—CALM1—Alzheimer's disease	5.16e-06	6e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—BCHE—Alzheimer's disease	5.15e-06	5.99e-05	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—APOE—Alzheimer's disease	5.15e-06	5.98e-05	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—CAV1—Alzheimer's disease	5.1e-06	5.92e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—PPARGC1A—Alzheimer's disease	5.09e-06	5.91e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—HMOX1—Alzheimer's disease	5.07e-06	5.89e-05	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—VEGFA—Alzheimer's disease	5.04e-06	5.86e-05	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—PTGS2—Alzheimer's disease	4.92e-06	5.72e-05	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—NOS3—Alzheimer's disease	4.89e-06	5.68e-05	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—PTGS2—Alzheimer's disease	4.88e-06	5.67e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—PLCB1—Alzheimer's disease	4.86e-06	5.65e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—PPARGC1A—Alzheimer's disease	4.79e-06	5.57e-05	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—MTHFR—Alzheimer's disease	4.79e-06	5.56e-05	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—MAPK8—Alzheimer's disease	4.79e-06	5.56e-05	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling by GPCR—AKT1—Alzheimer's disease	4.77e-06	5.55e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—HMOX1—Alzheimer's disease	4.77e-06	5.55e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	4.77e-06	5.54e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—PPARGC1A—Alzheimer's disease	4.75e-06	5.52e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—LPL—Alzheimer's disease	4.75e-06	5.51e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—HMOX1—Alzheimer's disease	4.73e-06	5.5e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—ABCA1—Alzheimer's disease	4.71e-06	5.48e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—LPL—Alzheimer's disease	4.63e-06	5.38e-05	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—TGFB1—Alzheimer's disease	4.63e-06	5.38e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—ACHE—Alzheimer's disease	4.57e-06	5.3e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—INPP5D—Alzheimer's disease	4.51e-06	5.24e-05	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—PPARG—Alzheimer's disease	4.48e-06	5.21e-05	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—CALM1—Alzheimer's disease	4.47e-06	5.2e-05	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—PTGS2—Alzheimer's disease	4.47e-06	5.2e-05	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—APOE—Alzheimer's disease	4.46e-06	5.18e-05	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR downstream signaling—AKT1—Alzheimer's disease	4.44e-06	5.16e-05	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—VEGFA—Alzheimer's disease	4.42e-06	5.14e-05	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—CAV1—Alzheimer's disease	4.42e-06	5.13e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—CASP3—Alzheimer's disease	4.4e-06	5.12e-05	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—INS—Alzheimer's disease	4.4e-06	5.11e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—IL6—Alzheimer's disease	4.37e-06	5.08e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—LPL—Alzheimer's disease	4.37e-06	5.07e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—LPL—Alzheimer's disease	4.33e-06	5.03e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—ENO1—Alzheimer's disease	4.28e-06	4.97e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—PTGS1—Alzheimer's disease	4.28e-06	4.97e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—MTHFR—Alzheimer's disease	4.27e-06	4.97e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—CYP2D6—Alzheimer's disease	4.2e-06	4.87e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—MTHFR—Alzheimer's disease	4.17e-06	4.85e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—PPARGC1A—Alzheimer's disease	4.06e-06	4.72e-05	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—TGFB1—Alzheimer's disease	4.06e-06	4.71e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—MAPK8—Alzheimer's disease	4.05e-06	4.7e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—HMOX1—Alzheimer's disease	4.04e-06	4.7e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—AKT1—Alzheimer's disease	4.03e-06	4.69e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—CALM1—Alzheimer's disease	3.99e-06	4.64e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—APOE—Alzheimer's disease	3.98e-06	4.62e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—BCHE—Alzheimer's disease	3.98e-06	4.62e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—CAV1—Alzheimer's disease	3.94e-06	4.58e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—MTHFR—Alzheimer's disease	3.93e-06	4.57e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—CALM1—Alzheimer's disease	3.9e-06	4.53e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—MTHFR—Alzheimer's disease	3.9e-06	4.53e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—APOE—Alzheimer's disease	3.88e-06	4.51e-05	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—PPARG—Alzheimer's disease	3.88e-06	4.51e-05	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—NOS3—Alzheimer's disease	3.86e-06	4.48e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—CAV1—Alzheimer's disease	3.85e-06	4.47e-05	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—TP53—Alzheimer's disease	3.81e-06	4.43e-05	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—INS—Alzheimer's disease	3.81e-06	4.42e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—PLCB1—Alzheimer's disease	3.75e-06	4.36e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—VEGFA—Alzheimer's disease	3.74e-06	4.34e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—LPL—Alzheimer's disease	3.7e-06	4.3e-05	CbGpPWpGaD
Buprenorphine—CYP2C18—Metabolism—AKT1—Alzheimer's disease	3.69e-06	4.28e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—CALM1—Alzheimer's disease	3.67e-06	4.27e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—APOE—Alzheimer's disease	3.66e-06	4.25e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—CALM1—Alzheimer's disease	3.64e-06	4.23e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—ABCA1—Alzheimer's disease	3.64e-06	4.23e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—APOE—Alzheimer's disease	3.63e-06	4.22e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—CAV1—Alzheimer's disease	3.63e-06	4.21e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—CAV1—Alzheimer's disease	3.59e-06	4.18e-05	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—PTGS2—Alzheimer's disease	3.53e-06	4.1e-05	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—IL6—Alzheimer's disease	3.49e-06	4.05e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—PPARG—Alzheimer's disease	3.47e-06	4.03e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—TGFB1—Alzheimer's disease	3.43e-06	3.98e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—INS—Alzheimer's disease	3.4e-06	3.95e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—PPARG—Alzheimer's disease	3.38e-06	3.93e-05	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—TP53—Alzheimer's disease	3.34e-06	3.88e-05	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—NOS3—Alzheimer's disease	3.34e-06	3.88e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—MTHFR—Alzheimer's disease	3.33e-06	3.87e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—INS—Alzheimer's disease	3.32e-06	3.85e-05	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—AKT1—Alzheimer's disease	3.22e-06	3.74e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—PPARG—Alzheimer's disease	3.19e-06	3.7e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—PPARG—Alzheimer's disease	3.16e-06	3.67e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—PPARGC1A—Alzheimer's disease	3.13e-06	3.64e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—INS—Alzheimer's disease	3.13e-06	3.63e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—HMOX1—Alzheimer's disease	3.12e-06	3.63e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—CALM1—Alzheimer's disease	3.11e-06	3.61e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—APOE—Alzheimer's disease	3.1e-06	3.6e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—INS—Alzheimer's disease	3.1e-06	3.6e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—CAV1—Alzheimer's disease	3.07e-06	3.57e-05	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—IL6—Alzheimer's disease	3.06e-06	3.55e-05	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—PTGS2—Alzheimer's disease	3.05e-06	3.55e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—NOS3—Alzheimer's disease	2.98e-06	3.46e-05	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—AKT1—Alzheimer's disease	2.92e-06	3.39e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—NOS3—Alzheimer's disease	2.91e-06	3.38e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—LPL—Alzheimer's disease	2.85e-06	3.32e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—TP53—Alzheimer's disease	2.82e-06	3.28e-05	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—AKT1—Alzheimer's disease	2.82e-06	3.28e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—NOS3—Alzheimer's disease	2.74e-06	3.19e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—PTGS2—Alzheimer's disease	2.73e-06	3.17e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—NOS3—Alzheimer's disease	2.72e-06	3.16e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—PPARG—Alzheimer's disease	2.7e-06	3.14e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—PTGS2—Alzheimer's disease	2.66e-06	3.09e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—INS—Alzheimer's disease	2.65e-06	3.08e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—IL6—Alzheimer's disease	2.58e-06	3e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—MTHFR—Alzheimer's disease	2.57e-06	2.99e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—PTGS2—Alzheimer's disease	2.51e-06	2.91e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—PTGS2—Alzheimer's disease	2.49e-06	2.89e-05	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—AKT1—Alzheimer's disease	2.47e-06	2.87e-05	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—AKT1—Alzheimer's disease	2.45e-06	2.85e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—CALM1—Alzheimer's disease	2.4e-06	2.79e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—APOE—Alzheimer's disease	2.39e-06	2.78e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—AKT1—Alzheimer's disease	2.38e-06	2.77e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—CAV1—Alzheimer's disease	2.37e-06	2.75e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—NOS3—Alzheimer's disease	2.32e-06	2.7e-05	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—AKT1—Alzheimer's disease	2.25e-06	2.61e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—PTGS2—Alzheimer's disease	2.12e-06	2.47e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—PPARG—Alzheimer's disease	2.08e-06	2.42e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—INS—Alzheimer's disease	2.04e-06	2.37e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—NOS3—Alzheimer's disease	1.79e-06	2.08e-05	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—AKT1—Alzheimer's disease	1.77e-06	2.06e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—PTGS2—Alzheimer's disease	1.64e-06	1.9e-05	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—AKT1—Alzheimer's disease	1.53e-06	1.78e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—AKT1—Alzheimer's disease	1.37e-06	1.59e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—AKT1—Alzheimer's disease	1.34e-06	1.55e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—AKT1—Alzheimer's disease	1.26e-06	1.46e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—AKT1—Alzheimer's disease	1.25e-06	1.45e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—AKT1—Alzheimer's disease	1.07e-06	1.24e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—AKT1—Alzheimer's disease	8.24e-07	9.57e-06	CbGpPWpGaD
